Cận lâm sàng của tăng cường tuyến cận giáp nguyên phát và cấu trúc xương
Tóm tắt
Từ khóa
Tài liệu tham khảo
Arnold A., 2002, Molecular pathogenesis of primary hyperparathyroidism, Journal of Bone and Mineral Research, 17, N30
Adami S., 2002, Epidemiology of primary hyperparathyroidism in Europe, Journal of Bone and Mineral Research Supplement, 2, N18
Moosgaard B., 2006, Plasma 1,25‐dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function, Clinical Endocrinology, 66, 35, 10.1111/j.1365-2265.2006.02680.x
Neer R.M., 2001, Effect of parathyroid hormone (1–34) on fracture and bone mineral density in postmenopausal women with osteoporosis, New England Journal of Medicine, 350, 459
Nissenson R.A., 2001, The Parathyroids. Basic and Clinical Concepts, 93
Melsen F., 1978, A tetracycline based evaluation of bone resorption and bone turnover in hyperthyroidism and hyperparathyroidism, Acta Medica Scandinavica, 204, 97, 10.1111/j.0954-6820.1978.tb08406.x
Charon S.A., 1982, Effects of parathyroid hormone on remodeling of iliac trabecular bone packets in patients with primary hyperparathyroidism, Clinical Orthopaedics and Related Research, 162, 255
Broulick P., 1982, Osteon cross‐sectional size in the iliac crest: variation in normals and patients with osteoporosis, hyperparathyroidism, acromegaly, hypothyroidism and treated epilepsy, Acta Pathologica, Microbiologica et Immunologica Scandinavica A, 190, 339, 10.1111/j.1699-0463.1982.tb00104_90A.x
Eriksen E.F., 2002, Primary hyperparathyroidism: lessons from bone histomorphometry, Journal of Bone and Mineral Research, 17, N95
Bilezikian J.P., 1991, Characterization and evaluation of asymptomatic primary hyperparathyroidism, Journal of Bone and Mineral Research, 6, S85
Rao D.S., 2002, Role of vitamin D and calcium nutrition in disease expression and parathyroid tumour growth in primary hyperparathyroidism: a global perspective, Journal of Bone and Mineral Research, 17, N75
Frost H.M., 1965, A synchronous group of mammalian cells, whose in vivo behaviour can be studied, Henry Ford Medical Bulletin, 13, 161
Frost H.M., 1964, Charles C Thomas
Moosgaard B. Christensen S.E. Vestergaard P. Heickendorff L. Christiansen P.&Mosekilde L.(2007)Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism.Clinical Endocrinology 2007 November 2; [Epub ahead of print].
Moosgaard B., 2006, Plasma 25‐hydroxyvitamin D and not 1,25‐dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross‐sectional study, Clinical Endocrinology, 155, 237
Hosoi J., 1985, Regulation of melanin synthesis of B16 mouse melanoma cells by 1α,25‐dihydroxyvitamin D3 and retinoic acid, Cancer Research, 45, 1474
Thakker R.V., 1986, Circulating concentrations of 1,25‐dihydroxyvitamin D3 in patients with primary hyperparathyroidism, Bone and Mineral, 1, 137
Frølich A., 1996, Does the plasma concentration of 25‐hydroxyvitamin D determine the level of 1,25‐dihydroxyvitamin D in primary hyperparathyroidism, Mineral and Electrolyte Metabolism, 22, 203
Jorde R., 2004, Serum parathyroid hormone levels in smokers and non‐smokers. The fifth Tromso study, European Journal of Endocrinology, 152, 1
Peacock M., 1984, Osteoporosis, 463
Lumachi F. Camozzi V. Ermani H. Nardi A.&Luisetto G.(2007)Lumbar spine bone mineral density changes in patients with primary hyperparathyroidism according to age and gender.Annals of the New York Academy of Sciences July 26 [Epub ahead of print].
Lumachi F. Camozzi V. Ermani H. De Lotto F.&Luisetto G.(2007)Bone mineral density improvement after successful parathyroidectomy in pre‐ and postmenopausal women with primary hyperparathyroidism. A prospective study.Annals of the New York Academy of Sciences July 23 [Epub ahead of print].
Silverberg S.J. Rubin M.R. Faiman C. Peacock M. Shoback D.M. Smallridge R.C. Schwanauer L.E. Olson K.A. Klassen P.&Bilezikian J.P.(2007)Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma.Journal of Clinical Endocrinology and Metabolism July 31; [Epub ahead of print].
Gallagher J.C., 1973, The effect of ethinylestradiol on calcium and phosphorus metabolism of postmenopausal women with primary hyperparathyroidism, Clinical Science and Molecular Medicine, 45, 785
Haldimann B., 1982, Hyperparathyroidie Primaire de la femme agee: effect des oestrogenes sur le metabolism calcique, Schweizeriche Medizinische Wochenschrift, 112, 1242
Marcus R., 2002, The role of estrogens and related compounds in the management of primary hyperparathyroidism, Journal of Bone and Mineral Research, 17, N146
Delmas P.D., 2002, Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four‐year results from a randomized clinical trial, Journal of Clinical Endocrinology and Metabolism, 87, 3609, 10.1210/jcem.87.8.8750
Misiorowski W., 2005, Alendronate increases bone mineral density in patients with symptomatic primary hyperparathyroidism, Endokrynologia Polska, 56, 871